Skip to content

Handgrip Exercise for Arteriovenous Fistula Maturation

The Effects of Progressive Handgrip Exercise Training on Arteriovenous Fistula Maturation in Chronic Kidney Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01061008
Enrollment
31
Registered
2010-02-02
Start date
2008-01-31
Completion date
2012-01-31
Last updated
2014-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Exercise; arteriovenous fistula; chronic kidney disease

Brief summary

The purpose of this study is to investigate whether post operative progressive forearm exercise is effective in improving arteriovenous fistula maturation in chronic kidney disease patients.

Detailed description

The arteriovenous fistula is considered to be the gold standard form of access for haemodialysis patients, however only 37% of haemodialysis patients have this form of access. A possible explanation for this could be the high fistula failure rate due to the lack of maturation. Therefore interventions aimed at enhancing fistula maturation are warranted. One such intervention could be forearm exercise, however this recommendation is not evidence based. Therefore, the purpose of this study is to investigate whether a program of post operative progressive hand grip exercise can improve fistula maturation.

Interventions

OTHERPost operative progressive handgrip exercise

As soon as possible post operation the patient will commence an eight week progressive handgrip training intervention

OTHERTreatment as usual

Continue routine care, with removal of exercise information given to patients(if anye.g. do not give out squeeze balls)

Sponsors

Betsi Cadwaladr University Health Board
CollaboratorOTHER_GOV
Bangor University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stage 4-5 chronic kidney disease, attending for arteriovenous fistula creation in forearm

Exclusion criteria

* Are under the age of 18years; * Not able to exercise forearm safely (as decided by the patients consultant) * Have any other uncontrolled medical condition * Unable to withstand transiently raised systolic blood pressure by 35 mmHg and diastolic by 25 mmHg * Or are unable to give consent

Design outcomes

Primary

MeasureTime frameDescription
Venous Diameter.3 monthsMeasurements were made using duplex ultrasonagraphy. Measurements were made at predetermined distances 5 to 10 cm proximal to the anastomosis (dependent on wound dressings and turbulent flow around the anastomosis). The scanning position for each patient was traced using transparent sheets which allowed analogous measurement positions for all scans. Cross sectional vascular diameter measurements were made using conventional grey scale B Mode imaging. Diameters were measured from the inner edges of the vascular wall (Wiese & Nonnast-Daniel, 2004).

Secondary

MeasureTime frame
Maximum Handgrip Strength3 months
Handgrip Endurance3 months
Forearm Muscle Cross Sectional Area3 months

Countries

United Kingdom

Participant flow

Recruitment details

Patients with stage four and five CKD attending two renal units in North Wales, UK were invited to participate in the study.

Participants by arm

ArmCount
Handgrip Exercise
Handgrip exercise - patients allocated to this intervention will carry out an eight week post operative progressive handgrip exercise training program
16
Treatment as Usual15
Total31

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event01
Overall StudyBadiocephalic fistula failed32
Overall StudyDeath10
Overall StudyUnable to exercise following surgery10
Overall StudyWithdrawal by Subject13

Baseline characteristics

CharacteristicTreatment as UsualHandgrip ExerciseTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
15 Participants16 Participants31 Participants
Age, Continuous60 years
STANDARD_DEVIATION 11
52 years
STANDARD_DEVIATION 14
56 years
STANDARD_DEVIATION 12
Region of Enrollment
United Kingdom
15 participants16 participants31 participants
Sex: Female, Male
Female
4 Participants5 Participants9 Participants
Sex: Female, Male
Male
11 Participants11 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
2 / 100 / 9
serious
Total, serious adverse events
0 / 100 / 9

Outcome results

Primary

Venous Diameter.

Measurements were made using duplex ultrasonagraphy. Measurements were made at predetermined distances 5 to 10 cm proximal to the anastomosis (dependent on wound dressings and turbulent flow around the anastomosis). The scanning position for each patient was traced using transparent sheets which allowed analogous measurement positions for all scans. Cross sectional vascular diameter measurements were made using conventional grey scale B Mode imaging. Diameters were measured from the inner edges of the vascular wall (Wiese & Nonnast-Daniel, 2004).

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
Handgrip ExerciseVenous Diameter.5.78 mmStandard Deviation 0.51
Treatment as UsualVenous Diameter.6.42 mmStandard Deviation 0.89
Secondary

Forearm Muscle Cross Sectional Area

Time frame: 3 months

Secondary

Handgrip Endurance

Time frame: 3 months

Secondary

Maximum Handgrip Strength

Time frame: 3 months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026